COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis

Clinical Cancer Research

Volumn 14, Issue 16, 2008, Pages 5061-5068

  Ning Fang, Ma ^a,b   Lau, Sze Hang ^c   Hu, Liang ^c   Xie, Dan ^a   Wu, Jun ^e   Yang, Jun ^e   Wang, Yi ^f   Wu, Meng Chao ^f   Fung, Jackie ^b   Bai, Xueyan ^e   Tzang, Chi Hung ^d   Fu, Li ^b   Yang, Mengsu ^d   Su, Yan An ^e   Guan, Xin Yuan ^a,c  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d CITY UNIVERSITY OF HONG KONG   (Hong Kong)

^e GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^f SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROTEIN X; HEPATITIS B VIRUS X PROTEIN; TRANSACTIVATOR PROTEIN;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MICROARRAY ANALYSIS; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR GROWTH; XENOGRAFT; ANIMAL; CELL TRANSFORMATION; CHEMISTRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; GENETICS; HEPATITIS B; LIVER TUMOR; METABOLISM; NORTHERN BLOTTING; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY; VIRUS GENE; VIRUS INFECTION;

ANIMALS; APOPTOSIS; BLOTTING, NORTHERN; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENES, VIRAL; HEPATITIS B; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LIVER NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE ARRAY ANALYSIS; TRANS-ACTIVATORS; TRANSFECTION; TUMOR VIRUS INFECTIONS;

EID: 52649139395     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-5082     Document Type: Article

References (29)

1. BlockTM, Mehta AS, Fimmel CJ, Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003;22:5093-107.
2. El-Serag HB, Mason AC, Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 2001;33:62-5.
3. Thorgeirsson SS, GrishamJW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002;31:339-46.
4. Montalto G, Gervello M, Giannitrapani L, Dantona F, Terranova A, Gastagnetta LA. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann N YAcad Sci 2002;963:13-20.
5. Benn J, Schneider RJ. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci US A1995;92:11215-19.
6. Lucito R, Schneider RJ. Hepatitis B virus X protein activates transcription factor NF-B without a requirement for protein kinase C. J Virol 1992;66:983-91.
7. Kekule AS, Lauer U, Weiss L, Luber B, Hofschneider PH. Hepatitis B virus transactivator HBx uses a tumor promoter signalling pathway. Nature 1993;361:742-5.
8. Maguire HF, Hoeffler JP, Siddiqui A. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 1991;252:842-4.
9. Doria M, Klein N, Lucito R, Schneider RJ. Hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J 1995;14:4747-57.
10. Klein N, Schneider RJ. Activation of Src family kinases by hepatitis B virus HBx protein, and coupled signaling to Ras. Mol Cell Biol 1997;17:6427-36.
11. Natoli G, Avantaggiati ML, Chririllo P, Puri PL, lanni A, Balsano C. ras- and raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene 1994;9:2837-43.
12. Henkler F, Lopes AR, Jones M, Koshy R. Erk-independent partial activation of AP-1 sites by the hepatitis B virus HBx protein. J Gen Virol 1998;79:2737-42.
13. WangY,Wu MC, Sham JS, Zhang W, Wu WQ, Guan XY. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue detected by tissue microarray. J Pathol 2002;197:610-6.
14. Tu H, Bonura C, Giannini C, et al. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res 2001;61:7803-10.
15. lavarone M.Trabut JB, Delpuech O, et al. Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection. J Hepatol 2003;39:253-61.
16. Wang Y, Lau SH, Sham JST,Wu MC,WangT, Guan XY. Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellular carcinogenesis. Oncogene 2004;23:142-8.
17. Pang RW, LeeTK, Man K, et al. PIN1 expression contributes to hepatic carcinogenesis. J Pathol 2006;210:19-25.
18. SuYA,Trent JM. Isolation of tumor suppressor genes in melanoma by cDNA microarray. In: Nicklolff BJ, editor. Methods in Molecular Medicine, Totowa (NJ): The Humana Press Inc.; 2001.
19. Takahashi K, AkahaneY, Hino K, Ohta Y Mishiro S. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch Virol 1998; 143:2313-26.
20. Baptista M, Kramvis A, Kew MC. High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. Hepatology 1999:29:946-53.
21. Arbuthnot P, Capovilla A, Kew M. Putative role of hepatitis B virus X protein in hepatocarcinogenesis:effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways. J Gastroenterol Hepatol 2000;15:357-68.
22. Diao J, Garces R, Richardson CD. X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev 2001;12:189-205.
23. Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol 2001;36:651-60.
24. TanakaY, ShirakataY Kaneniwa N, Koike K. The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1. Oncogene 2006;25:633-42.
25. Kumar V, Jayasuryan N, Kumar R. A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function. Proc Natl Acad Sci US A1996;93:5647-52.
26. Su F, Schneider RJ. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor α. Proc Natl Acad Sci U S A1997;94:8744-9.
27. Kim H, Lee H, Yun Y. X-gene product of hepatitis B virus induces apoptosis in liver cell. J Biol Chem 1998;273:381-5.
28. Takada S, ShirakataY, Kaneniwa N, Koike K. Association of hepatitis B virus X protein with mitochondria causes mitochondrial aggregation at the nuclear periphery, leading to cell death. Oncogene 1999:18:6965-73.
29. Kim HK, Seong BL. Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP and enhancement of death-inducing signal. EMBO J 2003:22:2104-16.